Celgene Werkstudent (m/w) Regulatory Affairs in Munich, Germany


Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.


  • Pflege des Tracking Systems

  • Unterstützung bei Aktualisierungen der Roten und Gelben Liste

  • Übersetzung von Dokumenten und Korrespondenzen

  • Implementierung von Änderungen in der gedruckten Version der Fachinformation

  • Unterstützung bei der Vorbereitung von länderspezifischen Anträgen für klinischen Studien

  • Allgemeine administrative Tätigkeiten

  • Korrekturlesen von aktualisierten behördlichen Informationsdokumenten (z.B. SmPC, PIL)

Erforderliche Qualifikationen:

  • Starke Identifikation mit den Werten von Celgene

  • Eingeschriebene/r Student/in im Bereich Medizin, Pharmazie oder Naturwissenschaften

  • Sehr gute deutsche und englische Sprachkenntnisse in Wort und Schrift

  • Sicherer Umgang mit Microsoft-Office-Anwendungen

  • Fähigkeit in einem Team, aber auch selbständig zu arbeiten

  • Sorgfältigkeit und hohe Zuverlässigkeit

  • Effiziente und effektive Arbeitsweise

  • Kenntnisse über die klinische Arzneimittelentwicklung oder klinische Studien sind von Vorteil



At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE